Evidence map›Paper›PMID 32757689›Full record

ArticleJournal of receptor and signal transduction research2021

α

Robert S Papay, Dianne M Perez

Open access · greenAbstract read
In one paragraph

Article in Journal of receptor and signal transduction research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. αInternational journal of molecular sciences · 2023
    Review
  7. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.International journal of molecular sciences · 2021
    Review
  8. Current Developments on the Role of αFrontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Robert S PapayThe Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA.
Dianne M PerezThe Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA.ORCID https://orcid.org/0000-0002-1790-5776
Cleveland Clinic · US

Funding

Early Stage Studies of a Novel Positive Allosteric Modulator of the Alpha1-Adrenergic Receptor to Treat Alzheimer's DiseaseR01AG066627 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI PEREZ, DIANNE M · 2020 to 2024
$2.0M
NIA NIH HHS R01 AG066627
6 · The paper itself

Abstract

The role of catecholamine receptors in cardiac energy metabolism is unknown. α

Indexed as

AcetophenonesAMP-Activated Protein Kinase KinasesAnimalsBenzopyransEnergy MetabolismGlucoseHumansMiceMyocardial IschemiaMyocytes, CardiacOxidation-ReductionPhenylephrineProtein KinasesPyrazolesPyrimidinesReceptors, Adrenergic, alpha-1AcetophenonesAMP-Activated Protein Kinase KinasesBenzopyransdorsomorphinGlucosePhenylephrineProtein KinasesPyrazolesPyrimidinesReceptors, Adrenergic, alpha-1rottlerinalpha1-adrenergicGlucoseG-protein coupled receptormetabolismoxidation

Identifiers

PMID32757689
PMCPMC7862428
OpenAlexW3047574394

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.